• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国坏疽性脓皮病的发病率、死亡率和疾病相关性:一项回顾性队列研究。

Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study.

机构信息

Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

J Invest Dermatol. 2012 Sep;132(9):2166-70. doi: 10.1038/jid.2012.130. Epub 2012 Apr 26.

DOI:10.1038/jid.2012.130
PMID:22534879
Abstract

Pyoderma gangrenosum (PG) is an important disease with significant complications. The objectives of this study were to determine incidence and mortality of PG and strength of reported associations. A retrospective cohort study was completed using computerized medical records from the General Practice Research Database, a large representative UK database. Patients with PG and three groups of age-, sex-, and practice-matched controls--general population, rheumatoid arthritis (RA), and inflammatory bowel disease (IBD) controls--were included in the study. Incidence and mortality were determined and validation undertaken to inform diagnostic accuracy. In all there were 313 people with the median age of 59 (interquartile range 41-72) years, and of them 185 (59%) were female. The adjusted incidence rate standardized to European standard population was 0.63 (95% confidence interval (CI) 0.57-0.71) per 100,000 person-years. The risk of death was three times higher than that for general controls (adjusted hazard ratio=3.03, 95% CI 1.84-4.73, P<0.001), 72% higher than that for IBD controls (adjusted hazard ratio=1.72, 95% CI 1.17-2.59, P=0.013), with a borderline increase compared with RA controls (adjusted hazard ratio=1.55, 95% CI 1.01-2.37, P=0.045). Disease associations were present in 110 (33%) participants: IBD, n=67 (20.2%); RA, n=39 (11.8%); and hematological disorders, n=13 (3.9%). To our knowledge, there are no previous population-based studies of the epidemiology of PG, an important disease with significantly increased mortality.

摘要

坏疽性脓皮病(PG)是一种重要的疾病,具有显著的并发症。本研究的目的是确定 PG 的发病率和死亡率以及报告的相关性的强度。这项回顾性队列研究使用了来自一般实践研究数据库(一个大型的英国代表性数据库)的计算机化医疗记录。研究纳入了 PG 患者和三组年龄、性别和实践匹配的对照者:一般人群、类风湿关节炎(RA)和炎症性肠病(IBD)对照者。确定了发病率和死亡率,并进行了验证以告知诊断准确性。共有 313 名患者,中位年龄为 59 岁(四分位距 41-72 岁),其中 185 名(59%)为女性。调整后的发病率标准化到欧洲标准人群为 0.63(95%置信区间(CI)0.57-0.71)/100,000 人年。死亡风险是一般对照者的三倍(调整后的危险比=3.03,95%CI 1.84-4.73,P<0.001),比 IBD 对照者高 72%(调整后的危险比=1.72,95%CI 1.17-2.59,P=0.013),与 RA 对照者相比有边缘性增加(调整后的危险比=1.55,95%CI 1.01-2.37,P=0.045)。110 名(33%)参与者存在疾病关联:IBD,n=67(20.2%);RA,n=39(11.8%);和血液系统疾病,n=13(3.9%)。据我们所知,以前没有关于 PG 的流行病学的基于人群的研究,PG 是一种重要的疾病,死亡率显著增加。

相似文献

1
Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study.英国坏疽性脓皮病的发病率、死亡率和疾病相关性:一项回顾性队列研究。
J Invest Dermatol. 2012 Sep;132(9):2166-70. doi: 10.1038/jid.2012.130. Epub 2012 Apr 26.
2
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.年龄与坏疽性脓皮病临床表现和合并症的关系。
JAMA Dermatol. 2018 Apr 1;154(4):409-413. doi: 10.1001/jamadermatol.2017.5978.
3
The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey.潜在疾病状态对坏疽性脓皮病患者结局的影响:一项全国性调查。
J Am Acad Dermatol. 2018 Oct;79(4):659-663.e2. doi: 10.1016/j.jaad.2018.02.007. Epub 2018 Feb 10.
4
Association of All-Cause and Cause-Specific Mortality Risks With Pyoderma Gangrenosum.坏疽性脓皮病与全因和病因特异性死亡率风险的关联。
JAMA Dermatol. 2023 Feb 1;159(2):151-159. doi: 10.1001/jamadermatol.2022.5437.
5
Comorbidities of pyoderma gangrenosum: a retrospective multicentric analysis of 126 patients.坏疽性脓皮病的合并症:对126例患者的回顾性多中心分析
Br J Dermatol. 2018 Jul;179(1):218-219. doi: 10.1111/bjd.16463. Epub 2018 May 15.
6
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.炎症性肠病的肠外表现可能比先前报道的更为少见。
Dig Dis Sci. 2016 Sep;61(9):2619-26. doi: 10.1007/s10620-016-4195-1. Epub 2016 May 19.
7
Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.溃疡性结肠炎相关性坏疽性脓皮病:系统评价和荟萃分析。
Dig Dis Sci. 2020 Sep;65(9):2675-2685. doi: 10.1007/s10620-019-05999-4. Epub 2020 Jan 10.
8
Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.1997 年至 2018 年英国巩膜炎的流行病学:基于人群的 1100 万患者分析及巩膜炎与感染性和免疫介导性炎症性疾病的相关性。
Arthritis Rheumatol. 2021 Jul;73(7):1267-1276. doi: 10.1002/art.41709. Epub 2021 Jun 6.
9
Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.炎症性关节炎相关坏疽性脓皮病:系统评价。
Clin Rheumatol. 2021 Oct;40(10):3963-3969. doi: 10.1007/s10067-021-05768-7. Epub 2021 May 18.
10
Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis.美国坏疽性脓皮病的流行率估计:年龄和性别调整后的人群分析。
J Am Acad Dermatol. 2020 Aug;83(2):425-429. doi: 10.1016/j.jaad.2019.08.001. Epub 2019 Aug 7.

引用本文的文献

1
Pyoderma Grangrenosum.坏疽性脓皮病
Clin Pract Cases Emerg Med. 2025 May;9(2):242-244. doi: 10.5811/cpcem.1675.
2
Pyoderma Gangrenosum in a Patient with Crohn's Disease Treated with Adalimumab: A Case-Based Review and Systematic Review of the Current Literature.用阿达木单抗治疗的克罗恩病患者发生坏疽性脓皮病:基于病例的回顾及当前文献的系统评价
Clin Pract. 2025 Mar 11;15(3):57. doi: 10.3390/clinpract15030057.
3
Resolution of Pyoderma Gangrenosum During Adjuvant Breast Cancer Therapy.辅助性乳腺癌治疗期间坏疽性脓皮病的消退
J Clin Med. 2025 Feb 17;14(4):1320. doi: 10.3390/jcm14041320.
4
The Changing Landscape of Clinical Research in Pyoderma Gangrenosum.坏疽性脓皮病临床研究的不断变化态势
J Invest Dermatol. 2025 Jun;145(6):1279-1282. doi: 10.1016/j.jid.2024.12.023. Epub 2025 Feb 8.
5
Pyoderma Gangrenosum With Severe Ankle Ankylosis Complicated by Rheumatoid Arthritis Successfully Treated Using Anti-tumor Necrosis Factor: A Case Report.使用抗肿瘤坏死因子成功治疗的伴有严重踝关节强直并合并类风湿关节炎的坏疽性脓皮病:一例报告
Cureus. 2024 Dec 12;16(12):e75614. doi: 10.7759/cureus.75614. eCollection 2024 Dec.
6
Pyoderma Gangrenosum: A Retrospective Case Series of 44 Patients.坏疽性脓皮病:44例患者的回顾性病例系列
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024265. doi: 10.5826/dpc.1404a265.
7
Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of menin-KMT2A inhibitor therapy for acute myeloid leukaemia.坏疽性脓皮病样嗜中性皮病作为急性髓系白血病的Menin-KMT2A抑制剂治疗的不良反应。
Ann Hematol. 2024 Dec;103(12):5985-5988. doi: 10.1007/s00277-024-06127-7. Epub 2024 Nov 30.
8
Treatment of systemic sclerosis complicated with pyoderma gangrenosum with adalimumab: A case report of a rare disease.阿达木单抗治疗系统性硬化症合并坏疽性脓皮病 1 例:罕见病例报告。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241300137. doi: 10.1177/03946320241300137.
9
Navigating Therapeutic Challenges of Pyoderma Gangrenosum in Felty's Syndrome: A Case Report and Literature Review.应对费尔蒂综合征中坏疽性脓皮病的治疗挑战:一例报告及文献综述
Cureus. 2024 Oct 14;16(10):e71428. doi: 10.7759/cureus.71428. eCollection 2024 Oct.
10
Hospital admissions for pyoderma gangrenosum in Spain (1999-2021): Epidemiological and clinical characteristics, temporal trends, and factors associated with poor prognosis and higher cost.西班牙坏疽性脓皮病的住院情况(1999 - 2021年):流行病学和临床特征、时间趋势以及与预后不良和高成本相关的因素
Health Sci Rep. 2024 Oct 8;7(10):e2286. doi: 10.1002/hsr2.2286. eCollection 2024 Oct.